Search - Université de Tours Access content directly

Filter your results

59 Results
authIdHal_s : denis-mulleman

Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance.

Eric Toussirot , Edouard Pertuiset , Antoine Martin , Sylvie Melac-Ducamp , Michel Alcalay , et al.
Journal of Rheumatology, 2006, 33 (5), pp.1027-8
Journal articles hal-00465223v1

Pattern of demyelination occuring during anti-TNF alpha therapy: a French national survey.

R. Seror , C. Richez , Christelle Sordet , S. Rist , L. Gossec , et al.
Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.330
Conference papers hal-00320158v1

Effect of Hyaluronic Acid in Symptomatic Hip Osteoarthritis A Multicenter, Randomized, Placebo-Controlled Trial

Pascal Richette , Philippe Ravaud , Thierry Conrozier , Liana Euller-Ziegler , Bernard Mazieres , et al.
Arthritis and Rheumatism, 2009, 60 (3), pp.824-830
Journal articles hal-00617951v1

Optimizing TNF alpha antagonist therapy in patients with spondyloarthritis: Why and how?

Daniel Wendling , Clement Prati , Philippe Goupille , Denis Mulleman
Joint Bone Spine, 2011, 78 (3), pp.225-227
Journal articles hal-00617876v1

Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseases

Emilie Bucourt , Virginie Martaille , Denis Mulleman , Philippe Goupille , Isabelle Joncker-Vannier , et al.
Joint Bone Spine, 2017, 84 (2), pp.203-207. ⟨10.1016/j.jbspin.2016.03.006⟩
Journal articles hal-01980735v1

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases

Erwin Dreesen , Peter Bossuyt , Denis Mulleman , Ann Gils , Dora Pascual-Salcedo
Clinical Pharmacology: Advances and Applications, 2017, Volume 9, pp.101-111. ⟨10.2147/CPAA.S138414⟩
Journal articles hal-01980768v1

Adalimumab concentration-based tapering strategy: as good as the recommended dosage

Denis Mulleman , Alejandro Balsa
Annals of the Rheumatic Diseases, 2018, 77 (4), pp.473-475. ⟨10.1136/annrheumdis-2017-212376⟩
Journal articles hal-01980770v1

Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study

Aurélien Dinh , Maxime Jean , Frédérique Bouchand , Benjamin Davido , Alexis Descatha , et al.
International Journal of Rheumatology, 2016, 2016, pp.1-4. ⟨10.1155/2016/9345467⟩
Journal articles hal-01980802v1

The underlying inflammatory chronic disease influences infliximab pharmacokinetics

Christophe Passot , Denis Mulleman , Theodora Bejan-Angoulvant , Alexandre Aubourg , Stephanie Willot , et al.
mAbs, 2016, 8 (7), pp.1407-1416. ⟨10.1080/19420862.2016.1216741⟩
Journal articles hal-01980816v1

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial

Emilie Ducourau , Theo Rispens , Marine Samain , Emmanuelle Dernis , Fabienne Le Guilchard , et al.
RMD Open : Rheumatic & Musculoskeletal Diseases, 2020, 6 (1), pp.e001047. ⟨10.1136/rmdopen-2019-001047⟩
Journal articles hal-02439716v1

The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition

Amina Bensalem , Guillaume Cartron , Ulrich Specks , Denis Mulleman , Emmanuel Gyan , et al.
Clinical Pharmacokinetics, 2022, 61 (3), pp.423-437. ⟨10.1007/s40262-021-01081-3⟩
Journal articles hal-03482193v1

Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis

Denis Mulleman , Delphine Chu Miow Lin , Emilie Ducourau , Patrick Emond , David Ternant , et al.
Ther. Drug Monit., 2010, 32 (2), pp.232-236
Journal articles hal-00616781v1

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.

Louis Bernard , Aurélien Dinh , Idir Ghout , David Simo , Valerie Zeller , et al.
The Lancet, 2014, pp.61233-2. ⟨10.1016/S0140-6736(14)61233-2⟩
Journal articles hal-01115445v1
Image document

Rhumatologie, la multitude des options

Jacques Morel , Denis Mulleman
Médecine/Sciences, 2019, 35 (12), pp.1029-1033. ⟨10.1051/medsci/2019204⟩
Journal articles hal-02519947v1

Etude comparée de la personnalité au cours de la fibromyalgie et d’autres maladies rhumatologiques

Virginie Martaille , Emilie Bucourt , Robert Courtois , Isabelle Joncker-Vannier , Elisabeth Diot , et al.
Revue du Rhumatisme, 2011, 1
Journal articles hal-02864307v1

Evaluation of two strategies (initial methotrexate monotherapy versus its combination with adalimumab) in management of early active rheumatoid arthritis during the first year of evolution: data from the GEPARD trial.

M. Soubrier , Xavier Puechal , Jean Sibilia , Xavier Mariette , O. Meyer , et al.
Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.331
Conference papers hal-00320161v1

Infliximab for treating axial spondylarthropathy in everyday practice

Denis Mulleman , Philippe Goupille , I. Griffoul , Bruno Giraudeau , Benhamou Cl , et al.
Joint Bone Spine, 2009, 76, pp.39-43
Journal articles hal-00375632v1

Infliximab concentration is predictive of control of disease activity and maintenance of treatment in rheumatoid arthritis.

Lin D. Chu Miow , Emilie Ducourau , Denis Mulleman , P. Emond , Denis Ternant , et al.
Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. Suppl. II:177 (THU-0131)
Conference papers hal-00320106v1

Revue critique des traitements percutanés de la radiculalgie par hernie discale lombaire. In : Le Rachis, sous la direction de F Lecouvet, P Goupille, P Guigui, A Feydy, T Moser, M Wybier.

Philippe Goupille , Denis Mulleman , S. Mammou , I. Griffoul , J.P. Valat
Sauramps ed., pp.69-78, 2008
Books hal-00320483v1

Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Theodora Bejan-Angoulvant , David Ternant , Fadela Daoued , Frédéric Medina , Louis Bernard , et al.
Arthritis & rheumatology, 2017, 69 (1), pp.108-113. ⟨10.1002/art.39841⟩
Journal articles hal-01980809v1

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration

David Ternant , Christophe Passot , Alexandre Aubourg , Philippe Goupille , Celine Desvignes , et al.
Clinical Pharmacokinetics, 2018, 57 (9), pp.1173-1184. ⟨10.1007/s40262-017-0621-6⟩
Journal articles hal-02372850v1

Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration

Celine Desvignes , Soujanya Edupuganti , François Darrouzain , Anne-Claire Duveau , Amy Loercher , et al.
Bioanalysis, 2015, 7 (10), pp.1253-1260. ⟨10.4155/bio.15.30⟩
Journal articles hal-02372930v1

Subluxing arthropathy : an unusual manifestation of the antisynthetase syndrome

Denis Mulleman , O. Meyer , H. Charlanne , P. Cherin , Yannick Allanore , et al.
Other publications hal-00375864v1

Comparaison des cinq grands traits de personnalité dans la fibromyalgie et les autres maladies rhumatismales

Emilie Bucourt , Virginie Martaille , Denis Mulleman , Philippe Goupille , Isabelle Joncker-Vannier , et al.
Revue du Rhumatisme, 2018, 85 (2), pp.188-194. ⟨10.1016/j.rhum.2017.07.008⟩
Journal articles hal-02864153v1

Nonlinear pharmacokinetics of rituximab in anti-neutrophil cytoplasmic antibody associated vasculitis.

Denis Mulleman , Amina Bensalem , David Ternant , Gilles Paintaud , Divi Cornec , et al.
EULAR 2019, Jun 2019, MADRID, Spain
Conference poster hal-02151041v1

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis

Frédéric Medina , Chamaida Plasencia , Philippe Goupille , Gilles Paintaud , Alejandro Balsa , et al.
Therapeutic Drug Monitoring, 2017, 39 (4), pp.360-363. ⟨10.1097/FTD.0000000000000400⟩
Journal articles hal-01980745v1

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis

Gilles Paintaud , Jean-Camille Meric , Denis Mulleman , Emilie Ducourau , Charlotte Magdelaine-Beuzelin , et al.
Fundamental & Clinical Pharmacology, 2009, 23, pp.29-29
Journal articles hal-00616867v1

Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited

Amina Bensalem , Denis Mulleman , Gilles Paintaud , Nicolas Azzopardi , Valerie Gouilleux-Gruart , et al.
Clinical Pharmacokinetics, 2019, ⟨10.1007/s40262-019-00826-5⟩
Journal articles hal-02316414v1

Body surface area, erythrocyte sedimentation rate, methotrexate and antibodies to infliximab influence the pharmacokinetics of infliximab in rheumatoid arthritis

Gilles Paintaud , Emilie Ducourau , David Ternant , A. Gorondan , B. Legoff , et al.
Fundamental & Clinical Pharmacology, 2010, 24, pp.51-51
Journal articles hal-00616804v1
Image document

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases.

Emilie Ducourau , Denis Mulleman , Gilles Paintaud , Delphine Chu Miow Lin , Francine Lauféron , et al.
Arthritis Research and Therapy, 2011, 13 (3), pp.R105. ⟨10.1186/ar3386⟩
Journal articles hal-00922822v1